Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mtabho, CM"'
Autor:
Aarnoutse, RE, Kibiki, GS, Reither, K, Semvua, HH, Haraka, F, Mtabho, CM, Mpagama, SG, van den Boogaard, J, Sumari-de Boer, IM, Magis-Escurra, C, Wattenberg, M, Logger, JGM, Te Brake, LHM, Hoelscher, M, Gillespie, SH, Colbers, A, Phillips, PPJ, Plemper van Balen, G, Boeree, MJ, PanACEA Consortium
Publikováno v:
Antimicrobial agents and chemotherapy, vol 61, iss 11
In a multiple-dose-ranging trial, we previously evaluated higher doses of rifampin in patients for 2 weeks. The objectives of the current study were to administer higher doses of rifampin for a longer period to compare the pharmacokinetics, safety/to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::043f76518f850ff5ff1b1fe1ccf9a781
https://escholarship.org/uc/item/08z4903k
https://escholarship.org/uc/item/08z4903k
Autor:
Mtabho CM; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Moshi, Tanzania., Semvua HH; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Moshi, Tanzania., van den Boogaard J; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.; Radboud university medical center, Department of Lung Diseases & Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Irongo CF; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.; National Tuberculosis and Leprosy Programme, Kilimanjaro Region, Tanzania., Boeree MJ; Radboud university medical center, Department of Lung Diseases & Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Colbers A; Radboud university medical center, Department of Pharmacy & Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Burger DM; Radboud university medical center, Department of Pharmacy & Radboud Institute for Health Sciences, Nijmegen, The Netherlands., van Crevel R; Radboud university medical center, Department of Internal Medicine & Radboud Institute for Health Sciences, Nijmegen, The Netherlands., van der Ven AJAM; Radboud university medical center, Department of Internal Medicine & Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Kibiki GS; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Moshi, Tanzania., Tostmann A; Radboud university medical center, Department of Lung Diseases & Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Aarnoutse RE; Radboud university medical center, Department of Pharmacy & Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Dec 01; Vol. 74 (12), pp. 3537-3545.
Autor:
Aarnoutse RE; Radboud University Medical Center, Department of Pharmacy, Nijmegen, the Netherlands.; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Kibiki GS; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Tumaini University, Moshi, Tanzania., Reither K; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Semvua HH; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Tumaini University, Moshi, Tanzania., Haraka F; Ifakara Health Institute, Bagamoyo, Tanzania., Mtabho CM; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Tumaini University, Moshi, Tanzania., Mpagama SG; Kibong'oto National Tuberculosis Hospital, Sanya Juu, Tanzania., van den Boogaard J; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Tumaini University, Moshi, Tanzania.; Radboud University Medical Center, Department of Lung Diseases, Nijmegen, the Netherlands., Sumari-de Boer IM; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Tumaini University, Moshi, Tanzania.; Radboud University Medical Center, Department of Internal Medicine, Nijmegen, the Netherlands., Magis-Escurra C; Radboud University Medical Center, Department of Lung Diseases, Nijmegen, the Netherlands., Wattenberg M; Radboud University Medical Center, Department of Medical Microbiology, Nijmegen, the Netherlands., Logger JGM; Radboud University Medical Center, Department of Pharmacy, Nijmegen, the Netherlands., Te Brake LHM; Radboud University Medical Center, Department of Pharmacy, Nijmegen, the Netherlands Lindsey.teBrake@radboudumc.nl.; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Radboud University Medical Center, Department of Lung Diseases, Nijmegen, the Netherlands., Hoelscher M; Medical Centre of the University of Munich (LMU), Division of Infectious Diseases and Tropical Medicine, Munich, Germany.; German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany., Gillespie SH; School of Medicine, University of St. Andrews, North Haugh, St. Andrews, United Kingdom., Colbers A; Radboud University Medical Center, Department of Pharmacy, Nijmegen, the Netherlands.; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Phillips PPJ; MRC Clinical Trials Unit at UCL, London, United Kingdom., Plemper van Balen G; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Radboud University Medical Center, Department of Lung Diseases, Nijmegen, the Netherlands., Boeree MJ; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Radboud University Medical Center, Department of Lung Diseases, Nijmegen, the Netherlands.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2017 Oct 24; Vol. 61 (11). Date of Electronic Publication: 2017 Oct 24 (Print Publication: 2017).
Autor:
Tostmann A; Department of Respiratory Diseases, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. A.Tostmann@elg.umcn.nl, Mtabho CM, Semvua HH, van den Boogaard J, Kibiki GS, Boeree MJ, Aarnoutse RE
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2013 Jul; Vol. 57 (7), pp. 3208-13. Date of Electronic Publication: 2013 Apr 29.
Autor:
Semvua HH; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Moshi, Kilimanjaro, Tanzania. hadija.semvua@gmail.com, Mtabho CM, Fillekes Q, van den Boogaard J, Kisonga RM, Mleoh L, Ndaro A, Kisanga ER, van der Ven A, Aarnoutse RE, Kibiki GS, Boeree MJ, Burger DM
Publikováno v:
Antiviral therapy [Antivir Ther] 2013; Vol. 18 (1), pp. 105-13. Date of Electronic Publication: 2012 Oct 05.
Autor:
Suba M; Department of Internal Medicine, Kilimanjaro Christian Medical Centre, Tumaini University, and Kilimanjaro Clinical Research Institute, P.O. Box 3010 Moshi, Tanzania., Ayana SM; Department of Internal Medicine, Kilimanjaro Christian Medical Centre, Tumaini University, and Kilimanjaro Clinical Research Institute, P.O. Box 3010 Moshi, Tanzania., Mtabho CM; Department of Internal Medicine, Kilimanjaro Christian Medical Centre, Tumaini University, and Kilimanjaro Clinical Research Institute, P.O. Box 3010 Moshi, Tanzania., Kibiki GS; Department of Internal Medicine, Kilimanjaro Christian Medical Centre, Tumaini University, and Kilimanjaro Clinical Research Institute, P.O. Box 3010 Moshi, Tanzania.
Publikováno v:
Tanzania journal of health research [Tanzan J Health Res] 2010 Oct; Vol. 12 (4), pp. 302-5.
Autor:
Mtabho CM; Kilimanjaro Clinical Research Institute, Moshi, Tanzania. bonaventz@yahoo.com, Irongo CF, Boeree MJ, Aarnoutse RE, Kibiki GS
Publikováno v:
Tropical medicine & international health : TM & IH [Trop Med Int Health] 2010 May; Vol. 15 (5), pp. 496-501. Date of Electronic Publication: 2010 Mar 08.